Citation

Alanee S, Russo P. Eur. J. Cancer Care 2012; 21(6): 817-821.

Affiliation

Division of Urology, Surgery Department, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA.

Copyright

(Copyright © 2012, John Wiley and Sons)

DOI

10.1111/j.1365-2354.2012.01366.x

PMID

22624649

Abstract

Depression, anxiety and aggression are documented in testis cancer patients and can result in death from suicides; however, their risk of suicide is not defined. We report suicide rates among testis cancer patients in the USA and determine factors associated with higher rates. We used the Surveillance, Epidemiology, and End Results (SEER) database maintained by the National Cancer Institute to identify patients diagnosed with testis cancer between 1995 and 2008. Multivariate analysis was used to assess factors affecting suicide rate. Among 23 381 patients followed for 126 762 person-years, suicide rate was 26.0 per 100 000 person-years, with the average corresponding rate in the US population aged 25-44 years being 21.5 per 100 000 person-years; the calculated standardised mortality ratio for death by suicide was 1.2 [95% confidence interval (CI): 1.1-2.1]. The standardised mortality ratio for suicide was 1.5 (95% CI: 1.1-2.1) in ages less than 30 years, and 1.8 (95% CI: 1.3-2.4) in men of races other than White and Black. Other patient and disease characteristics were not predictive. In conclusion, patients with testis cancer have a 20% increase in the risk of suicide over that of the general population, and races other than White and Black and younger patients may commit suicide at higher rates.

Language: en